Skip to main content

Investor

By Emily Olsen | 01:28 pm | June 09, 2022
Shipments of wearables declined 3% year-over-year, according to a report by the International Data Corporation.
HIMSS22 Europe
By Sam Shah | 03:05 am | June 09, 2022
The pandemic has forced major investment in digital health to help expand and create solutions that support patients and healthcare professionals through one of the most challenging times in history says Prof Sam Shah, Founder Faculty of Future Health, CoMD with Ulster University, visiting faculty UCL Global Business School for Health and HIMSS22 Europe speaker.
By Emily Olsen | 01:47 pm | June 08, 2022
The round brings the company's total raise to $83 million.
By Emily Olsen | 11:11 am | June 08, 2022
The Wolf+Friends app will relaunch this summer to include support groups facilitated by DotCom's mental health professionals as well as educational content.
By Emily Olsen | 02:01 pm | June 07, 2022
The suit claims Teladoc, CEO Jason Gorevic and CFO Mala Murthy made misleading statements or failed to disclose that increased competition was affecting its BetterHelp mental health segment and its chronic care business.
By Emily Olsen | 12:10 pm | June 07, 2022
This marks the company's second deal this year. It announced plans to acquire a network of fertility clinics in February.
HIMSS22 Europe
By Tammy Lovell | 07:10 am | June 07, 2022
Bringing together leaders from the supply side and the demand side of hospital digitalisation could be the key to a smoother transformation journey, as attendees at HIMSS22 Europe will find out. 
By Emily Olsen | 02:21 pm | June 06, 2022
Also: Drug discovery platform Insilico Medicine raises $60 million, Women's virtual care startup Visana Health brings in $2.6 million and digital reproductive care clinic Choix scoops up $1 million.
By Emily Olsen | 12:22 pm | June 03, 2022
CEO Eren Bali said the company was winding down some of its COVID-19-related services and plans to shift its focus from growth to profitability.
By Emily Olsen | 02:08 pm | June 02, 2022
Also: Autism-focused SpectrumAi and cancer clinical trial platform Massive Bio both scooped up $9 million.